$14.38
0.050.35%
At close: -
$14.38
0.000.00%
After Hours: Mar 7, 4:00 PM EDT
Comments
Loading...
Tourmaline Bio Earnings Estimates, EPS & Revenue | NASDAQ:TRML | Benzinga
Tourmaline Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 21
EPS Estimate
$-0.900
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Tourmaline Bio using advanced sorting and filters.
Data brought to you by Benzinga APIs
Tourmaline Bio (TRML) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.78 | $-0.79 | 1.27 % |
| Q2 | 2024-08-08 | $-0.68 | $-0.71 | 4.23 % |
| Q1 | 2024-05-13 | $-0.55 | $-0.67 | 17.9 % |
Tourmaline Bio (TRML) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Tourmaline Bio (NASDAQ:TRML) reporting earnings?
Tourmaline Bio (TRML) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Tourmaline Bio (NASDAQ:TRML)?
The Actual EPS was $-0.78, which beat the estimate of $-0.79.
What were Tourmaline Bio’s (NASDAQ:TRML) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.